Jeroen Vanderhoeven

1.6k total citations
17 papers, 738 citations indexed

About

Jeroen Vanderhoeven is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Virology. According to data from OpenAlex, Jeroen Vanderhoeven has authored 17 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Pediatrics, Perinatology and Child Health and 5 papers in Virology. Recurrent topics in Jeroen Vanderhoeven's work include HIV Research and Treatment (5 papers), HIV/AIDS Research and Interventions (5 papers) and HIV/AIDS drug development and treatment (5 papers). Jeroen Vanderhoeven is often cited by papers focused on HIV Research and Treatment (5 papers), HIV/AIDS Research and Interventions (5 papers) and HIV/AIDS drug development and treatment (5 papers). Jeroen Vanderhoeven collaborates with scholars based in United States, Switzerland and Argentina. Jeroen Vanderhoeven's co-authors include Martin Markowitz, Viviana Simon, Arlene Hurley, Bharat Ramratnam, Sophia Lannon, Kristina M. Adams Waldorf, Michael J. Louie, Michael G. Gravett, Neil Parkin and Chris Chung and has published in prestigious journals such as PLoS ONE, Journal of Virology and The Journal of Infectious Diseases.

In The Last Decade

Jeroen Vanderhoeven

17 papers receiving 710 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeroen Vanderhoeven United States 12 376 341 183 147 145 17 738
Elizabeth Hawkins United States 12 218 0.6× 348 1.0× 164 0.9× 116 0.8× 76 0.5× 17 522
RA Kaslow United States 8 78 0.2× 88 0.3× 197 1.1× 170 1.2× 52 0.4× 8 529
I. Grosch-Wörner Germany 9 245 0.7× 411 1.2× 238 1.3× 56 0.4× 34 0.2× 28 603
Lisa M. Cranmer United States 13 382 1.0× 652 1.9× 320 1.7× 46 0.3× 37 0.3× 43 824
Brian A. Reikie Canada 9 80 0.2× 155 0.5× 161 0.9× 30 0.2× 34 0.2× 13 465
James D. Arthur United States 10 83 0.2× 87 0.3× 122 0.7× 119 0.8× 51 0.4× 18 486
Bassam H. Rimawi United States 12 28 0.1× 381 1.1× 239 1.3× 368 2.5× 104 0.7× 27 790
Olubukola Ojuola Gambia 10 74 0.2× 194 0.6× 394 2.2× 88 0.6× 72 0.5× 11 679
Laurent Finkielsztejn France 12 290 0.8× 348 1.0× 123 0.7× 51 0.3× 19 0.1× 27 525
Petronella Muresan United States 15 228 0.6× 289 0.8× 325 1.8× 14 0.1× 32 0.2× 27 575

Countries citing papers authored by Jeroen Vanderhoeven

Since Specialization
Citations

This map shows the geographic impact of Jeroen Vanderhoeven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeroen Vanderhoeven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeroen Vanderhoeven more than expected).

Fields of papers citing papers by Jeroen Vanderhoeven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeroen Vanderhoeven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeroen Vanderhoeven. The network helps show where Jeroen Vanderhoeven may publish in the future.

Co-authorship network of co-authors of Jeroen Vanderhoeven

This figure shows the co-authorship network connecting the top 25 collaborators of Jeroen Vanderhoeven. A scholar is included among the top collaborators of Jeroen Vanderhoeven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeroen Vanderhoeven. Jeroen Vanderhoeven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Armistead, Blair, Michelle M. Coleman, Brian Johnson, et al.. (2020). MicroRNA Signature of Epithelial-Mesenchymal Transition in Group B Streptococcal Infection of the Placental Chorioamniotic Membranes. The Journal of Infectious Diseases. 222(10). 1713–1722. 8 indexed citations
2.
Porreco, Richard P., Matthew D. Sekedat, Allan T. Bombard, et al.. (2019). Evaluation of a novel screening method for fetal aneuploidy using cell-free DNA in maternal plasma. Journal of Medical Screening. 27(1). 1–8. 5 indexed citations
3.
Garite, Thomas J., Kimberly Maurel, Arup Das, et al.. (2017). Vasa Previa: Diagnosis and Management. Obstetric Anesthesia Digest. 37(2). 66–66. 3 indexed citations
4.
Garite, Thomas J., Kimberly Maurel, A. Das, et al.. (2016). Vasa previa: diagnosis and management. American Journal of Obstetrics and Gynecology. 215(2). 223.e1–223.e6. 58 indexed citations
5.
McAdams, Ryan M., Craig J. Bierle, Erica Boldenow, et al.. (2015). Choriodecidual Group B Streptococcal Infection Induces miR-155-5p in the Fetal Lung in Macaca nemestrina. Infection and Immunity. 83(10). 3909–3917. 24 indexed citations
6.
Lannon, Sophia, Katherine A. Guthrie, Jeroen Vanderhoeven, & Hilary S. Gammill. (2015). Uterine Rupture Risk After Periviable Cesarean Delivery. Obstetrics and Gynecology. 125(5). 1095–1100. 45 indexed citations
7.
Lannon, Sophia, Jeroen Vanderhoeven, David A. Eschenbach, Michael G. Gravett, & Kristina M. Adams Waldorf. (2014). Synergy and Interactions Among Biological Pathways Leading to Preterm Premature Rupture of Membranes. Reproductive Sciences. 21(10). 1215–1227. 62 indexed citations
8.
Vanderhoeven, Jeroen, Craig J. Bierle, Raj P. Kapur, et al.. (2014). Group B Streptococcal Infection of the Choriodecidua Induces Dysfunction of the Cytokeratin Network in Amniotic Epithelium: A Pathway to Membrane Weakening. PLoS Pathogens. 10(3). e1003920–e1003920. 50 indexed citations
9.
Vanderhoeven, Jeroen, et al.. (2014). Neonatal morbidity occurs despite pulmonary maturity prior to 39 weeks gestation. Journal of Perinatology. 34(4). 322–325. 4 indexed citations
10.
Marshall, Nicole, Jeroen Vanderhoeven, Karen Eden, Sally Segel, & Jeanne‐Marie Guise. (2014). Impact of simulation and team training on postpartum hemorrhage management in non-academic centers. The Journal of Maternal-Fetal & Neonatal Medicine. 28(5). 495–499. 48 indexed citations
11.
McAdams, Ryan M., Jeroen Vanderhoeven, Richard P. Beyer, et al.. (2013). Correction: Choriodecidual Infection Downregulates Angiogenesis and Morphogenesis Pathways in Fetal Lungs from Macaca Nemestrina. PLoS ONE. 8(2). 1 indexed citations
12.
McAdams, Ryan M., Jeroen Vanderhoeven, Richard P. Beyer, et al.. (2012). Choriodecidual Infection Downregulates Angiogenesis and Morphogenesis Pathways in Fetal Lungs from Macaca Nemestrina. PLoS ONE. 7(10). e46863–e46863. 25 indexed citations
13.
Ramratnam, Bharat, Ruy M. Ribeiro, He Tian, et al.. (2003). Intensification of Antiretroviral Therapy Accelerates the Decay of the HIV-1 Latent Reservoir and Decreases, But Does Not Eliminate, Ongoing Virus Replication. JAIDS Journal of Acquired Immune Deficiency Syndromes. 35(1). 33–37. 98 indexed citations
14.
Simon, Viviana, Neal N. Padte, Jeroen Vanderhoeven, et al.. (2003). Infectivity and Replication Capacity of Drug-Resistant Human Immunodeficiency Virus Type 1 Variants Isolated during Primary Infection. Journal of Virology. 77(14). 7736–7745. 35 indexed citations
15.
Simon, Viviana, Jeroen Vanderhoeven, Arlene Hurley, et al.. (2002). Evolving patterns of HIV-1 resistance to antiretroviral agents in newly infected individuals. AIDS. 16(11). 1511–1519. 106 indexed citations
16.
Markowitz, Martin, Xia Jin, Arlene Hurley, et al.. (2002). Discontinuation of Antiretroviral Therapy Commenced Early during the Course of Human Immunodeficiency Virus Type 1 Infection, with or without Adjunctive Vaccination. The Journal of Infectious Diseases. 186(5). 634–643. 112 indexed citations
17.
Kijak, Gustavo H., Viviana Simon, Peter Balfe, et al.. (2002). Origin of Human Immunodeficiency Virus Type 1 Quasispecies Emerging after Antiretroviral Treatment Interruption in Patients with Therapeutic Failure. Journal of Virology. 76(14). 7000–7009. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth Hawkins Breakdown of academic impact, for papers by RA Kaslow Breakdown of academic impact, for papers by I. Grosch-Wörner Breakdown of academic impact, for papers by Lisa M. Cranmer Breakdown of academic impact, for papers by Brian A. Reikie Breakdown of academic impact, for papers by James D. Arthur Breakdown of academic impact, for papers by Bassam H. Rimawi Breakdown of academic impact, for papers by Olubukola Ojuola Breakdown of academic impact, for papers by Laurent Finkielsztejn Breakdown of academic impact, for papers by Petronella Muresan
Rankless by CCL
2026